Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,140 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

NCT06035497

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
Locations
  • Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
  • Local Institution - 0011 Nagoya, Aichi-ken, Japan
  • Local Institution - 0024 Toyohashi, Aichi-ken, Japan
  • Local Institution - 0017 Kamogawa, Chiba, Japan
View all 40 locations
View Trial Details
Active, Not Recruiting

Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)

NCT04546620

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Colchester General Hospital Colchester, Essex, United Kingdom
  • East Kent Hospitals NHS Foundation Trust Canterbury, Kent, United Kingdom
  • Monklands Hospital Airdrie, United Kingdom
  • Victoria Hospital Blackpool, United Kingdom
View all 33 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT04384484

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Redlands Community Hospital Redlands, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 144 locations
View Trial Details
Active, Not Recruiting

DS-3201b in Participants With Lymphomas

NCT02732275

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope National Medical center Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT04666038

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Southern Cancer Center, P.C. Daphne, Alabama, United States
  • Mitchell Cancer Institute -University of South Alabama Mobile, Alabama, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Arizona Oncology Associates, P.C. - HOPE Tucson, Arizona, United States
View all 232 locations
View Trial Details
Active, Not Recruiting

Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy

NCT01382082

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Delaware/Christiana Care NCORP Newark, Delaware, United States
  • Delaware/Christiana Care NCORP (CHRISTIANA) Newark, Delaware, United States
  • Heartland Decatur, Illinois, United States
  • Kansas City Clinical Oncology Program Prairie Village, Kansas, United States
View all 29 locations
View Trial Details

Related conditions